Navigation Links
Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
Date:4/14/2008

h laboratories and counseling facilities located across the U.S., Genzyme Genetics offers extensive reproductive and cancer testing services, supported by innovative technology and a commitment to quality service and trusted information. Genzyme Genetics is a business unit of Genzyme Corporation.

In addition to SMA carrier testing and prenatal diagnosis, Genzyme offers a broad carrier test menu including cystic fibrosis testing with 97 mutations, fragile X testing and 11 carrier tests for the Ashkenazi Jewish population; an industry-leading cytogenetics program; an extensive maternal serum screening program (which includes first trimester, integrated and second trimester screening); and an innovative infertility testing program.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme's press releases and other company information are available at http://www.genzyme.com and by calling Gen
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Presentation of New Positive Data on Carticel(R)
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
4. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
5. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
6. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
7. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
8. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
9. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
10. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
11. Genetics Determine Optimal Drug Dose of Common Anticoagulant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... DIEGO , May 28, 2015   ... clinical-stage biopharmaceutical company leveraging its molecular adhesion and ... for sickle cell disease, heart failure, and arterial ... resigning from the Company,s Board of Directors. Mr. ... conflict of interest given his role as President ...
(Date:5/28/2015)... , May 28, 2015  Transportation Insight, ... announces winning the SDCE100 Award for the ... Demand Chain Executive magazine. Transportation Insight ... goods distributor quantify and control supply chain ... highly competitive market. Deploying Transportation Insight,s Enterprise ...
(Date:5/28/2015)... -- National Community Pharmacists Association (NCPA) CEO B. ... in response to a new report released ... number of generic drug costs increased substantially in 2013: ... expressed by NCPA and underscores the need for action ... Moreover, a 2015 survey of 700 community pharmacists concluded ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... present a company update at the Cowen Health Care Conference in ... Interested parties may access a live audio webcast of ... www.BMRN.com .  A replay of the call will be archived ...
... 2011 Uptake Medical ® Corp., a developer of ... emphysema , announced today that Scott Huennekens, President and ... ) has joined the company,s Board of Directors. ... Volcano since April 2002. He led the company from a ...
Cached Medicine Technology:BioMarin to Present at the Cowen Health Care Conference 2Uptake Medical Announces Scott Huennekens Elected to Board of Directors 2
(Date:5/29/2015)... (PRWEB) May 29, 2015 News: 2015-2016 ... , Company website: http://www.carsonenergy.com , In ... rapidly, due to the boom in US shale production ... in order to regain market share from US shale ... realized by putting more oil out into the marketplace, ...
(Date:5/29/2015)... Wimbledon Health Partners, the leading on-site ... and NCV testing, is proud to announce the ... EKG interpretation of athletes. , Sudden cardiac ... athletic activity. New findings presented in February have played ... cardiac safety in athletes. Physiologic adaptations in athletic individuals ...
(Date:5/29/2015)... Thursday, May 21st was the inaugural Red Nose ... of life came together to raise money for kids living ... campaign dedicated to raising money for children and young people ... laugh, the people at Hands-On Seminars decided to host their ... provided food, fun and laughter to their visitors, while raising ...
(Date:5/29/2015)... Belviq for weight loss , also ... medication. In 2012, the FDA approved Belviq specifically ... BMI >30. It is also approved for individuals ... weight-related health condition such as high blood pressure, diabetes, ... for weight loss focuses on the brain’s appetite center. ...
(Date:5/28/2015)... External Counterpulsation (EECP/ECP) has been used extensively all ... There are a growing number of people with advanced ... angina and these patients are often times not amenable ... “No option” patients are a sizable cohort of population ... considered unacceptable for heart stent or bypass. The Heart ...
Breaking Medicine News(10 mins):Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 2Health News:Belviq for Weight Loss is Now Available to Qualified Diet Doc Patients Nationwide 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2
... BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC.OB), a biopharmaceutical,company ... BioSpecifics, President, Tom Wegman, will present a,corporate overview ... Healthcare,Conference on Wednesday, November 12, 2008, at 10:20am ... York, NY., A live webcast of the ...
... Nov. 7 Eric Abrue (30), a,quadriplegic patient who is ... a historic and highly successful LASIK procedure performed,by Drs. Jeffrey ... in a,playground in 1986, breaking his neck and severing his ... unable to move any,part of his body below his upper ...
... Power and Associates Also Names Kaiser Permanente "Highest ... DENVER, Nov. 7 Kaiser Permanente Colorado is ... plan in,Colorado according to a joint ranking by ... for Quality Assurance (NCQA)., To view the ...
... Study finds these doctors have better results, including survival ... heart surgeons may be the best choice for adults ... new study suggests. , A congenital heart defect occurs ... blood vessels near the heart. , The researchers analyzed ...
... Children under the age of three who had hernia surgery ... later compared to children who had not undergone the surgery, ... School of Public Health and the College of Physicians and ... into the New York State Medicaid system between 1999 and ...
... Show at Nassau Coliseum, NEW YORK, Nov. 7 ... 2009 Concert Series -- a Valentine,s Day show,with Barry Manilow, ... will be held on February 14th, 2009 at Nassau Coliseum, ... 10th at 10am,through Ticketmaster.com or by calling Stand Up for ...
Cached Medicine News:Health News:Historic LASIK Surgery Performed on Quadriplegic Patient to Preserve his Communication Abilities 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 3Health News:Pediatric Heart Surgeons May Be Best Choice for Adults 2Health News:General anesthesia for hernia surgery in children and risk of later developmental problems 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
The Hydroflex Arthroscopic Irrigation Pump is simple to transport, set-up and tear down. The pump is streamlined with a simple control panel an no transducers or electronics to control flow. It is co...
... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
The OsteoJect Bone Cement Delivery System now offers leading technology to physicians with the first-ever reusable driver. The OsteoJect allows precise delivery of bone cement under active fluoro whi...
This high technology cast plaster cutter saw is very easy and comfortable to use....
Medicine Products: